ebomi
Colour theme
Sign in
Insider · CIK 0001635088 Also files as an issuer

Roivant Sciences Ltd.

CIK 0001635088 Name as filed on the most recent filing

Filed as Roivant Sciences Ltd. (27)

52 transaction lines · from 27 filings · filed 2018-04-04 to 2025-12-12 The span is the filing dates this catalog holds, not the entity's full filing history. Absence here is not evidence of absence at the SEC.

How this page attributes a trade

A line appears here when the filing that carries it names this CIK as a reporting owner, not only when the parser picked this CIK as the line's primary owner. That is why a joint filing appears on both owners' pages rather than vanishing from the second one. The catalog never merges two CIKs into one person and never splits one CIK into two: identity here is the SEC's own identifier and nothing else.

01

Issuers this insider has filed against

Ordered by last-seen filing date, newest first. Roles are as filed on the Form 4 and are not normalised.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-21 05:23 UTC.

No issuer is recorded

The catalog holds no filing linking this CIK to an issuer.

02

Transactions

Every stored Form 4 line naming this reporting owner, newest transaction date first. Each row links to the filing it came from.

52 transactions · Newest transaction date first, id breaking the tie.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-21 05:23 UTC.

Transactions filed by this insider
Direction Date Issuer Code Shares Price Value USD Filing
2025-12-12 Immunovant, Inc.
IMVT 		P, Open-market purchase 16,666,666 acquired 21.00 349,999,986.00 Form 4, filing 0001140361-25-045409
2025-01-13 Immunovant, Inc.
IMVT 		P, Open-market purchase 16,845,010 acquired 20.00 336,900,200.00 Form 4, filing 0001140361-25-001188
2023-10-02 Immunovant, Inc.
IMVT 		P, Open-market purchase 1,526,316 acquired 38.00 58,000,008.00 Form 4, filing 0001140361-23-046976
2022-10-06 Immunovant, Inc.
IMVT 		P, Open-market purchase 416,667 acquired 6.00 2,500,002.00 Form 4, filing 0001140361-22-036652
2020-09-04 Immunovant, Inc.
IMVT 		P, Open-market purchase 380,000 acquired 33.00 12,540,000.00 Form 4, filing 0001104659-20-102701
2020-04-16 Immunovant, Inc.
IMVT 		P, Open-market purchase 1,034,483 acquired 14.50 15,000,003.50 Form 4, filing 0001104659-20-048301
2020-02-24 Axovant Gene Therapies Ltd.
AXGT 		P, Open-market purchase 5,333,333 acquired 3.75 19,999,998.75 Form 4, filing 0001104659-20-026412
2019-12-27 Urovant Sciences Ltd.
UROV 		S, Open-market sale 22,860,013 disposed Not reported Not priced Form 4, filing 0001104659-19-077346
2019-12-27 Myovant Sciences Ltd.
MYOV 		S, Open-market sale 45,008,604 disposed Not reported Not priced Form 4, filing 0001104659-19-077345
2019-12-17 Myovant Sciences Ltd.
MYOV 		P, Open-market purchase 75,000 acquired 15.94 1,195,500.00 Form 4, filing 0001104659-19-073807
2019-12-16 Myovant Sciences Ltd.
MYOV 		P, Open-market purchase 131,541 acquired 14.97 1,969,168.77 Form 4, filing 0001104659-19-073807
2019-12-16 Myovant Sciences Ltd.
MYOV 		P, Open-market purchase 38,459 acquired 15.68 603,037.12 Form 4, filing 0001104659-19-073807
2019-12-04 Myovant Sciences Ltd.
MYOV 		P, Open-market purchase 72,471 acquired 17.04 1,234,905.84 Form 4, filing 0001104659-19-069974
2019-12-04 Myovant Sciences Ltd.
MYOV 		P, Open-market purchase 2,529 acquired 17.56 44,409.24 Form 4, filing 0001104659-19-069974
2019-12-02 Myovant Sciences Ltd.
MYOV 		P, Open-market purchase 113,668 acquired 18.21 2,069,894.28 Form 4, filing 0001104659-19-069974
2019-12-02 Myovant Sciences Ltd.
MYOV 		P, Open-market purchase 65,525 acquired 18.85 1,235,146.25 Form 4, filing 0001104659-19-069974
2019-11-25 Myovant Sciences Ltd.
MYOV 		P, Open-market purchase 3,500,000 acquired 15.00 52,500,000.00 Form 4, filing 0001104659-19-068249
2019-11-21 Myovant Sciences Ltd.
MYOV 		P, Open-market purchase 103,613 acquired 11.80 1,222,633.40 Form 4, filing 0001104659-19-066768
2019-11-21 Myovant Sciences Ltd.
MYOV 		P, Open-market purchase 18,293 acquired 12.38 226,467.34 Form 4, filing 0001104659-19-066768
2019-11-20 Myovant Sciences Ltd.
MYOV 		P, Open-market purchase 121,906 acquired 12.90 1,572,587.40 Form 4, filing 0001104659-19-066768
2019-06-19 Urovant Sciences Ltd.
UROV 		P, Open-market purchase 4,957 acquired 8.17 40,495.22 Form 4, filing 0001104659-19-036412
2019-06-18 Urovant Sciences Ltd.
UROV 		P, Open-market purchase 6,706 acquired 8.21 55,060.95 Form 4, filing 0001104659-19-036412
2019-06-17 Urovant Sciences Ltd.
UROV 		P, Open-market purchase 6,541 acquired 8.53 55,824.82 Form 4, filing 0001104659-19-036412
2019-06-14 Urovant Sciences Ltd.
UROV 		P, Open-market purchase 7,144 acquired 7.91 56,514.04 Form 4, filing 0001104659-19-035730
2019-06-13 Urovant Sciences Ltd.
UROV 		P, Open-market purchase 7,367 acquired 7.95 58,542.60 Form 4, filing 0001104659-19-035730
2019-06-12 Urovant Sciences Ltd.
UROV 		P, Open-market purchase 7,500 acquired 8.30 62,244.00 Form 4, filing 0001104659-19-035730
2019-06-11 Urovant Sciences Ltd.
UROV 		P, Open-market purchase 7,189 acquired 8.58 61,693.84 Form 4, filing 0001104659-19-034827
2019-06-10 Urovant Sciences Ltd.
UROV 		P, Open-market purchase 7,500 acquired 8.35 62,594.25 Form 4, filing 0001104659-19-034827
2019-06-07 Urovant Sciences Ltd.
UROV 		P, Open-market purchase 6,649 acquired 7.96 52,959.28 Form 4, filing 0001104659-19-034827
2019-06-06 Urovant Sciences Ltd.
UROV 		P, Open-market purchase 7,082 acquired 8.00 56,621.30 Form 4, filing 0001104659-19-034351
2019-06-05 Urovant Sciences Ltd.
UROV 		P, Open-market purchase 6,540 acquired 8.02 52,418.10 Form 4, filing 0001104659-19-034351
2019-06-04 Urovant Sciences Ltd.
UROV 		P, Open-market purchase 7,500 acquired 7.59 56,910.75 Form 4, filing 0001104659-19-034351
2019-06-04 Myovant Sciences Ltd.
MYOV 		P, Open-market purchase 2,424,242 acquired 8.25 19,999,996.50 Form 4, filing 0001104659-19-034348
2019-06-03 Urovant Sciences Ltd.
UROV 		P, Open-market purchase 5,424 acquired 7.71 41,814.70 Form 4, filing 0001104659-19-033504
2019-05-31 Urovant Sciences Ltd.
UROV 		P, Open-market purchase 5,071 acquired 7.70 39,042.14 Form 4, filing 0001104659-19-033504
2019-05-30 Urovant Sciences Ltd.
UROV 		P, Open-market purchase 6,951 acquired 7.97 55,417.54 Form 4, filing 0001104659-19-033504
2019-05-30 Urovant Sciences Ltd.
UROV 		P, Open-market purchase 300 acquired 8.91 2,671.98 Form 4, filing 0001104659-19-033504
2019-05-29 Urovant Sciences Ltd.
UROV 		P, Open-market purchase 6,882 acquired 7.55 51,983.19 Form 4, filing 0001104659-19-032471
2019-05-28 Urovant Sciences Ltd.
UROV 		P, Open-market purchase 3,807 acquired 7.68 29,244.61 Form 4, filing 0001104659-19-032471
2019-05-24 Urovant Sciences Ltd.
UROV 		P, Open-market purchase 3,796 acquired 7.70 29,233.38 Form 4, filing 0001104659-19-032471
2019-05-23 Urovant Sciences Ltd.
UROV 		P, Open-market purchase 4,802 acquired 7.76 37,252.00 Form 4, filing 0001104659-19-031524
2019-05-22 Urovant Sciences Ltd.
UROV 		P, Open-market purchase 5,033 acquired 8.06 40,557.93 Form 4, filing 0001104659-19-031524
2019-05-21 Urovant Sciences Ltd.
UROV 		P, Open-market purchase 9,995 acquired 8.52 85,108.42 Form 4, filing 0001104659-19-031524
2019-05-20 Urovant Sciences Ltd.
UROV 		P, Open-market purchase 8,285 acquired 7.98 66,141.64 Form 4, filing 0001104659-19-030609
2019-05-20 Urovant Sciences Ltd.
UROV 		P, Open-market purchase 1,715 acquired 8.39 14,383.19 Form 4, filing 0001104659-19-030609
2019-05-17 Urovant Sciences Ltd.
UROV 		P, Open-market purchase 6,200 acquired 7.36 45,641.30 Form 4, filing 0001104659-19-030609
2019-05-16 Urovant Sciences Ltd.
UROV 		P, Open-market purchase 5,408 acquired 6.79 36,718.16 Form 4, filing 0001104659-19-030609
2019-03-18 Axovant Sciences Ltd.
AXON 		P, Open-market purchase 6,666,667 acquired 1.50 10,000,000.50 Form 4, filing 0001104659-19-016010
2018-12-18 Axovant Sciences Ltd.
AXON 		P, Open-market purchase 10,000,000 acquired 1.00 10,000,000.00 Form 4, filing 0001104659-18-073897
2018-10-01 Urovant Sciences Ltd.
UROV 		P, Open-market purchase 2,678,571 acquired 14.00 37,499,994.00 Form 4, filing 0001104659-18-060344

This column is intentionally blank

No transaction line is stored for this reporting owner, though the catalog holds filings naming them. That happens when the filings report only holdings or only positions the store does not carry, and when a parse failed; each filing page states its own parse status.

Search the catalog
Codes on this page
P, Open-market purchase
Open-market purchase
S, Open-market sale
Open-market sale

Every value is as reported on the Form 4. A price the filing did not report is marked Not reported and no value is computed from it. Codes outside the open market, drawn in grey behind a dashed rule, are compensation and administrative machinery rather than a decision to trade at the prevailing price.

What this insider's stored lines contain

Exact counts over every stored line for this entity. This is a statement of composition, not a filter: the only filter this page offers is the open-market one above, because that is the only one an index serves today.

  • Open-market purchase 50
  • Open-market sale 2
  • Option exercise 0
  • Grant or award 0
  • Tax withholding 0
  • Disposition to the issuer 0
  • In-the-money option exercise 0

How to cite this page

ebomi catalog. Roivant Sciences Ltd., insider transactions. Retrieved 2026-08-21 from https://ebomi.com/insider/0001635088

Balogh, A. Insider trading. Scientific Data 10, 237 (2023) doi:10.1038/s41597-023-02147-6

This page as JSON The JSON twin is shaped by the same read model as this page, so the two cannot disagree. Its envelope carries the canonical URL, the retrieval time, the coverage claim, and the licence statement.